Anteris Technologies Global Corp. (AVR) vs 4D Molecular Therapeutics, Inc. (FDMT)
A side-by-side comparison of Anteris Technologies Global Corp. and 4D Molecular Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AVR
Anteris Technologies Global Corp.
$7.05HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
FDMT
4D Molecular Therapeutics, Inc.
$12.56HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — AVR vs FDMT
growth of $100 · dividends reinvested · last 2yAVR +34.8% (+16.1%/yr)FDMT +87.8% (+37.0%/yr)FDMT compounded faster over this window
AVR FDMT
AVR vs FDMT: by the numbers
- •AVR is the larger company ($685M vs $657M market cap).
- •Both run net losses; FDMT's is the smaller (-194.74% vs -4619.67% net margin).
- •FDMT grew revenue faster over the past five years (31.93% vs -18.92% CAGR).
Metrics side by side
Valuation
| Metric | AVR | FDMT |
|---|---|---|
| P/S ratio | 305.75 | 7.14 |
| P/B ratio | 2.73 | 1.61 |
Profitability
| Metric | AVR | FDMT |
|---|---|---|
| Gross margin | -16.57% | 91.05% |
| Operating margin | -4908.21% | -187.24% |
| Net margin | -4619.67% | -194.74% |
| ROE | -41.20% | -43.95% |
| ROIC | -41.63% | -44.30% |
Growth (annualized)
| Metric | AVR | FDMT |
|---|---|---|
| Revenue CAGR (5Y) | -18.92% | 31.93% |
| Total return CAGR (5Y) | N/A | -13.08% |
Frequently asked
- Which has grown faster, AVR or FDMT?
- Over the past five years, FDMT grew revenue faster — AVR at a -18.92% CAGR versus FDMT at 31.93%.
Go deeper
Dig into the metrics
Anteris Technologies Global ROE4D Molecular Therapeutics ROEAnteris Technologies Global operating margin4D Molecular Therapeutics operating marginAnteris Technologies Global revenue growth4D Molecular Therapeutics revenue growthAnteris Technologies Global free cash flow4D Molecular Therapeutics free cash flow
Anteris Technologies Global & 4D Molecular Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.